Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Institute of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, Jiangsu, China.
Cell Transplant. 2020 Jan-Dec;29:963689720917342. doi: 10.1177/0963689720917342.
Endothelial progenitor cells (EPCs) patrols the circulation and contributes to endothelial cell regeneration. Atherosclerotic renal artery stenosis (ARAS) induces microvascular loss in the stenotic kidney (STK). Low-energy shockwave therapy (SW) can induce angiogenesis and restore the STK microcirculation, but the underlying mechanism remains unclear. We tested the hypothesis that SW increases EPC homing to the swine STK, associated with capillary regeneration. Normal pigs and pigs after 3 wk of renal artery stenosis were treated with six sessions of low-energy SW (biweekly for three consecutive weeks) or left untreated. Four weeks after completion of treatment, we assessed EPC (CD34+/KDR+) numbers and levels of the homing-factor stromal cell-derived factor (SDF)-1 in the inferior vena cava and the STK vein and artery, as well as urinary levels of vascular endothelial growth factor (VEGF) and integrin-1β. Subsequently, we assessed STK morphology, capillary count, and expression of the proangiogenic growth factors angiopoietin-1, VEGF, and endothelial nitric oxide synthase . A 3-wk low-energy SW regimen improved STK structure, capillary count, and function in ARAS+SW, and EPC numbers and gradients across the STK decreased. Plasma SDF-1 and renal expression of angiogenic factors were increased in ARAS+SW, and urinary levels of VEGF and integrin-1β tended to rise during the SW regimen. In conclusion, SW improves ischemic kidney capillary density, which is associated with, and may be at least in part mediated by, promoting EPCs mobilization and homing to the stenotic kidney.
内皮祖细胞(EPC)在循环中巡逻,并有助于内皮细胞再生。动脉粥样硬化性肾动脉狭窄(ARAS)可导致狭窄肾脏(STK)中的微血管丢失。低能量冲击波治疗(SW)可诱导血管生成并恢复 STK 微循环,但潜在机制尚不清楚。我们假设 SW 增加了 EPC 向猪 STK 的归巢,与毛细血管再生有关。正常猪和肾动脉狭窄 3 周后的猪接受了六次低能量 SW 治疗(连续三周每两周一次)或未治疗。治疗完成 4 周后,我们评估了下腔静脉和 STK 静脉和动脉中的 EPC(CD34+/KDR+)数量以及归巢因子基质细胞衍生因子(SDF)-1的水平,以及尿中血管内皮生长因子(VEGF)和整合素-1β的水平。随后,我们评估了 STK 形态、毛细血管计数以及促血管生成生长因子血管生成素-1、VEGF 和内皮型一氧化氮合酶的表达。3 周的低能量 SW 方案改善了 ARAS+SW 中的 STK 结构、毛细血管计数和功能,EPC 数量和 STK 梯度降低。ARAS+SW 中血浆 SDF-1 和肾脏中血管生成因子的表达增加,SW 治疗期间尿中 VEGF 和整合素-1β的水平也有所升高。总之,SW 可改善缺血性肾脏毛细血管密度,这与促进 EPC 动员和归巢到狭窄肾脏有关,至少部分可能是通过这种机制介导的。